Neoadjuvant Hormonal Therapy Compared to Neoadjuvant Chemotherapy in Stage IIIB/C and IV Breast Cancer Patients
Condition: Breast Cancer Interventions: Drug: Aromatase Inhibitors (Arimidex); Drug: Tamoxifen; Procedure: SOB; Drug: FAC; Drug: Aromatase Inhibitors (Femara); Drug: Aromatase Inhibitors (Aromasin) Sponsor: Dharmais National Cancer Center Hospital Recruiting - verified December 2016
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Arimidex | Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | Hormonal Therapy | Hormones | Hospitals | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Tamoxifen